Chemotherapy + avelumab followed by avelumab + talazoparib
B9991030
Phase 3 small_molecule terminated
Quick answer
Chemotherapy + avelumab followed by avelumab + talazoparib for Ovarian Cancer is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Ovarian Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated